“Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV,” IRIN reports. The news service notes that “illegal use of pharmaceutical substances, mostly buprenorphine, is on the rise” in the country. “Buprenorphine was intended to be used to wean injecting drug users, also known as people who inject drugs (PWID), from narcotics like heroin, but has itself become a substance of addiction, with users injecting a liquid form of it,” the news service notes, adding, “Methadone, a pain reliever, suppresses withdrawal symptoms and blocks craving.”
The Global Fund to Fight AIDS, Tuberculosis and Malaria and the Nigerian government on Friday “signed two grant agreements … worth a total of $225 million to support programs that will prevent and treat malaria,” a Global Fund press release reports. According to the press release, the agreements “include an additional $50 million for bed nets, approved in an unusual move by the Global Fund Board that was linked to additional commitments by the government of Nigeria” (8/24). Global Fund Deputy Executive Director Debrework Zewdie “told top government functionaries that the [money] is meant to assure the international community that Nigeria is a worthy partner in the fight to eradicate malaria,” ThisDay writes, adding, “During a transformation of the fund’s grant management structure this year, Nigeria was identified as one of the 20 ‘high impact’ countries that are now receiving special attention” (8/26). Aigboje Aig-Imoukhuede, CEO of Access Bank and chair of the Friends of the Global Fund Africa, “described the grant as [an] opportunity for Nigeria to show leadership and commitment in the fight against malaria by committing more resources to save lives,” the Daily Trust notes (Atonko, 8/26).
Aidspan, an independent watchdog of the Global Fund, on Wednesday published Issue 192 of its “Global Fund Observer.” The issue features an article examining new reports released by the Office of the Inspector General on three audits and four diagnostic reviews; an article highlighting two reports on the impact of the cancellation of Round 11 by the Global Fund; and an article discussing the reaction to Spain’s Global Fund contribution, among others (8/15).
A new report, titled “Injection Drug Use in Ukraine” and published by the Center for Strategic & International Studies (CSIS), examines the challenges of providing HIV prevention and care services in the country, particularly to people who inject drugs (PWID), who accounted for “nearly 50 percent of new HIV infections registered in 2010,” according to the CSIS website. Authors Phillip Nieburg, senior associate and co-chair of the Prevention Committee of the CSIS HIV/AIDS Task Force, and Lisa Carty, senior adviser in the CSIS Global Health Policy Center, also examine how the Global Fund to Fight AIDS, Tuberculosis and Malaria and PEPFAR could help Ukraine “in advancing HIV prevention and other services for PWID,” the website notes (3/16).
Swazi, South African Activists March To U.S. Consulate In Johannesburg To Call For Emergency Global Fund Meeting
“Almost a thousand Swazi and South African HIV activists marched to the United States consulate in Johannesburg on [Thursday] to demand that the U.S. continue supporting the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria, and safeguard funding of its President’s Emergency Plan for AIDS Relief (PEPFAR),” PlusNews reports. “The march organizers — a coalition of international and regional HIV organizations, including the global medical charity Medecins Sans Frontieres (MSF), the World AIDS Campaign, and the AIDS Rights Alliance Southern Africa — also called on the British and Australian governments to join their American counterparts in kick-starting a response to solve the Global Fund’s financial crisis,” according to the news service.
NGOs Release Joint Statement Calling For Governments To Increase Payments To Global Fund To Fill Gap In TB Funding
Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that “[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed,” Reuters reports. The International HIV/AIDS Alliance, the Stop AIDS Campaign and Results UK said in the statement that the cancellation of Round 11 grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria was endangering the expansion of treatment and prevention programs, the news agency notes. The statement “called on governments to scale up funding of TB, HIV and malaria programs at a G20 meeting in Mexico in June in an effort to replenish the Global Fund with $2 billion,” according to Reuters (Mollins, 3/23).
Gabriel Jaramillo, the general manager of the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, said in an interview on Friday that “quite a few donors” to the fund “have earmarked portions of their donations to us, their contributions, to capacity-building,” the Associated Press/Washington Post reports. According to the AP, the Global Fund “is increasingly being forced to devote a portion of its donations to improving its own spending controls rather than disease-fighting,” the news service writes. “France, whose nearly $2.9 billion in donations have made it the fund’s second-largest contributor after the U.S., will sign a new pledging agreement this month requiring that five percent of its money go to tighten financial accountability among grant recipients, he said,” the AP writes.
Ukraine Security Secretary Says HIV, TB Remain Threat To Nation’s Security, Encourages Cooperation With Global Fund
Speaking about two bills concerning Ukraine’s cooperation with the Global Fund to Fight AIDS, Tuberculosis and Malaria, Ukraine Secretary of National Security and Defense Council Andriy Kliuyev said “[t]he epidemics of AIDS and tuberculosis [TB] remain a threat to national security in Ukraine and require redoubled efforts to treat and prevent these diseases,” Interfax reports. Submitted to Ukraine’s parliament by the Cabinet of Ministers, the two bills “propos[e] to exempt from taxes and duties all transactions connected with the use of grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria in Ukraine,” the news agency notes. “The NSDC secretary said the state should explore every avenue to minimize the sickness rate and create conditions for the treatment and prevention of dangerous diseases, adding that the grants of the Global Fund to Fight AIDS, Tuberculosis and Malaria are valuable support for Ukraine,” Interfax writes (3/3).
According to a study recently published in a special supplement of the Journal of Infectious Diseases, half of countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria provide tuberculosis (TB) services in prisons; “even when TB services were provided to prisoners, they were limited in scope; and “[f]ew of the programs receiving a grant from the Global Fund offered services dedicated to the treatment and prevention of multi-drug resistant TB (MDR-TB),” an aidsmap news story reports. TB is a leading cause of death among incarcerated individuals worldwide, aidsmap notes. The study authors concluded, “There is an urgent need to better understand the financing needs and cost-effective service delivery models for tuberculosis care in prisons,” according to the story (Carter, 3/30).
Japan on Monday provided a $340 million contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria, “the highest amount that Japan has ever made in 10 years of vigorous support for the Global Fund,” according to a fund press release. “This new contribution represents a significant increase over Japan’s previous highest contribution of $246 million in 2010” and “raises Japan’s contributions to the Global Fund to more than $1.6 billion since its creation in 2002,” the press release states (3/13).